CLINICAL_TRIALS
trial_result
· 2013-11-11
Clinical Trial Update: A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects [Phase 2]
Summary
Phase 2 dose-ranging trial of GSK1349572 with 2 NRTIs in therapy-naive HIV-1–infected subjects has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2013-11-11